Innovative molecular design to expedite lead compound identification and/or consider aspects of long-term biodegradation of biologically active molecules. The 2025 award will be presented at the Green ...
Small-molecule drug discovery was originally a compound-based activity. The process begins with the discovery of a biologically active compound, often a naturally occurring small molecule.
The function of many biologically active molecules requires the presence of carbon-nitrogen bonds in strategic positions. The biosynthetic pathways leading to such bonds can be bypassed through ...